Biohaven Completes Enrollment in RISE 3 Pivotal Focal Epilepsy Study with Opakalim, a Selective Kv7.2/7.3 Activator
Wavelet Medical Receives ARPA-H Award to Support Validation of Novel Fetal Brain Monitoring Technology
Yale Spinout CREW Raises $25M Series A to Scale Wastewater Treatment Optimization Technology as Climate Solution
Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer